UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P.3.d.077 Clinical Global Impression after aripiprazole once-monthly and paliperidone palmitate: Results from QUALIFY, a head-to-head study in schizophrenia

European neuropsychopharmacology, 2015-09, Vol.25, p.S525-S526

2015

Volltextzugriff (PDF)

P.3.d.084 Aripiprazole once-monthly is superior to paliperidone palmitate: results from QUALIFY, a randomized, head-to-head clinical study in schizophrenia

European neuropsychopharmacology, 2015-09, Vol.25, p.S529-S530

2015

Volltextzugriff (PDF)

P.3.d.080 Aripiprazole once-monthly and paliperidone palmitate in patients with schizophrenia stratified by age: Results from QUALIFY, a head-to-head study

European neuropsychopharmacology, 2015-09, Vol.25, p.S527-S528

2015

Volltextzugriff (PDF)

P.3.d.078 Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: Results from QUALIFY, a head-to-head study in schizophrenia

European neuropsychopharmacology, 2015-09, Vol.25, p.S526-S526

2015

Volltextzugriff (PDF)

Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System

The Journal of biological chemistry, 2000-10, Vol.275 (42), p.32452-32459

2000

Volltextzugriff (PDF)

Aripiprazole Once-monthly is Superior to Paliperidone Palmitate in a Randomized, Head-to-head Clinical Study

European psychiatry, 2015-03, Vol.30, p.923-923

2015

Volltextzugriff (PDF)

Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist

Nature medicine, 2002-08, Vol.8 (8), p.825-830

2002

Volltextzugriff (PDF)

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

International clinical psychopharmacology, 2017-05, Vol.32 (3), p.147-154

2017

Volltextzugriff (PDF)

The MCH receptor family: feeding brain disorders?

Current opinion in pharmacology, 2003-02, Vol.3 (1), p.85-89

Forray, Carlos

2003

Volltextzugriff (PDF)

Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF

The Journal of biological chemistry, 2000-12, Vol.275 (50), p.39324-39331

2000

Volltextzugriff (PDF)

Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression

Neuroscience letters, 2012-05, Vol.516 (1), p.85-88

2012

Volltextzugriff (PDF)

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia

Journal of medicinal chemistry, 2000-07, Vol.43 (14), p.2703-2718

2000

Volltextzugriff (PDF)

Neurotransmitter Receptors Mediate Cyclic GMP Formation by Involvement of Arachidonic Acid and Lipoxygenase

Proceedings of the National Academy of Sciences - PNAS, 1984-06, Vol.81 (12), p.3905-3909

1984

Volltextzugriff (PDF)

Expression Cloning of a Rat Hypothalamic Galanin Receptor Coupled to Phosphoinositide Turnover

The Journal of biological chemistry, 1997-09, Vol.272 (39), p.24612-24616

1997

Volltextzugriff (PDF)

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones

Journal of medicinal chemistry, 1999-11, Vol.42 (23), p.4764-4777

1999

Volltextzugriff (PDF)

Brain-derived neurotrophic factor (BDNF) gene polymorphisms: Influence on treatment response phenotypes of major depressive disorder

Toxicology letters, 2010-07, Vol.196, p.S105-S105

2010

Volltextzugriff (PDF)

On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex

Molecular pharmacology, 1990-06, Vol.37 (6), p.893-902

1990

Volltextzugriff (PDF)

Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor

The Journal of pharmacology and experimental therapeutics, 1989-08, Vol.250 (2), p.565

1989

Volltextzugriff (PDF)

The α1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human α1c subtype

Molecular pharmacology, 1994, Vol.45 (4), p.703-708

1994

Volltextzugriff (PDF)

Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands

Molecular pharmacology, 1992-08, Vol.42 (2), p.311-321

1992

Volltextzugriff (PDF)

Neurotensin Stimulates Inositol Phospholipid Metabolism and Calcium Mobilization in Murine Neuroblastoma Clone N1E‐115

Journal of neurochemistry, 1986-10, Vol.47 (4), p.1214-1218

1986

Volltextzugriff (PDF)

Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2643-2650

1998

Volltextzugriff (PDF)

Subtype selective α1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia

Expert opinion on investigational drugs, 1999-12, Vol.8 (12), p.2073-2094

1999

Volltextzugriff (PDF)

Effects of chronic exposure to ethanol on the prostaglandin E1 receptor-mediated response and binding in a murine neuroblastoma clone (N1E-115)

The Journal of pharmacology and experimental therapeutics, 1986-12, Vol.239 (3), p.687

1986

Volltextzugriff (PDF)

Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses

The Journal of pharmacology and experimental therapeutics, 1989-12, Vol.251 (3), p.992

1989

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(54)
Animals
(52)
Biological And Medical Sciences
(46)
Humans
(42)
Rats
(38)
Male
(36)
Medical Sciences
(27)
Pharmacology & Pharmacy
(26)
Pharmacology. Drug Treatments
(24)
Fundamental And Applied Biological Sciences. Psychology
(19)
Female
(17)
Adrenergic Alpha-Antagonists - Pharmacology
(14)
Neuropharmacology
(14)
Psychiatry
(13)
Chemistry, Medicinal
(12)
Mice
(12)
Rats, Sprague-Dawley
(12)
Adrenergic Alpha-1 Receptor Antagonists
(11)
Cell Line
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

P.3.d.077 Clinical Global Impression after aripiprazole once-monthly and paliperidone palmitate: Results from QUALIFY, a head-to-head study in schizophrenia

P.3.d.084 Aripiprazole once-monthly is superior to paliperidone palmitate: results from QUALIFY, a randomized, head-to-head clinical study in schizophrenia

P.3.d.080 Aripiprazole once-monthly and paliperidone palmitate in patients with schizophrenia stratified by age: Results from QUALIFY, a head-to-head study

P.3.d.078 Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: Results from QUALIFY, a head-to-head study in schizophrenia

Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System

Aripiprazole Once-monthly is Superior to Paliperidone Palmitate in a Randomized, Head-to-head Clinical Study

Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

The MCH receptor family: feeding brain disorders?

Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF

Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia

Neurotransmitter Receptors Mediate Cyclic GMP Formation by Involvement of Arachidonic Acid and Lipoxygenase

Expression Cloning of a Rat Hypothalamic Galanin Receptor Coupled to Phosphoinositide Turnover

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones

Brain-derived neurotrophic factor (BDNF) gene polymorphisms: Influence on treatment response phenotypes of major depressive disorder

On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex

Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor

The α1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human α1c subtype

Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands

Neurotensin Stimulates Inositol Phospholipid Metabolism and Calcium Mobilization in Murine Neuroblastoma Clone N1E‐115

Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate

Subtype selective α1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia

Effects of chronic exposure to ethanol on the prostaglandin E1 receptor-mediated response and binding in a murine neuroblastoma clone (N1E-115)

Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses

Suchergebnisse filtern